Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate Update

NEXT STORY
ALX Oncology to Present ALX148 Clinical Data at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
PREV STORY
Replimune Announces Presentation at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ovid Therapeutics Announces First Patient Randomized in the Phase 2 STARS Clinical Trial in Adults with Angelman Syndrome

NEW YORK, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics, a privately held biopharmaceutical ...

author_avatar
NASDAQ Market News

Samsung Bioepis Releases First Annual Sustainability Report

author_avatar
NASDAQ Market News

North America Sports Medicine Market 2020-2030: Consistent Innovation of New Products and Treatment Modalities

author_avatar
NASDAQ Market News